Archives: Products

Development of a biodegradable implant for the delivery of GLP-1 agonists, indicated for the treatment of metabolic syndrome. The feasibility study is expected shortly.

Biodegradable implant encapsulating dexamethasone for intravitreal use for 6 months. Glucocorticoid for the treatment of age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.